Nutraceutical M&A 2025-26: the deals, trends and strategic shifts reshaping the health and wellness market

By Emily Letton | Published: 1-Apr-2026
Regulatory Finance

From GLP-1-driven reformulation to billion-dollar functional beverage buyouts, the nutraceutical and supplement M&A market is undergoing its most dramatic reconfiguration in years

You need to be a subscriber to read this article.
Click here to find out more.

Consumers are rethinking what they eat, drink and which supplements they use and the M&A market is following close behind.

The past 18 months have seen legacy food and beverage giants scramble to acquire insurgent brands, GLP-1 adoption rewrite the supplement playbook and clinical credibility emerge as the defining currency of deal value. Nutraceutical Business Review maps the deals driving this transformation and what they signal for the sector.

Legacy players play catch-up

Nutraceutical M&A 2025-26: the deals, trends and strategic shifts reshaping the health and wellness market2025 marked a new era of aggressive, innovation-led portfolio reconfiguration for the food and beverage (F&B) industry. With PepsiCo's $1.95bn acquisition of Poppi and Hershey's purchase of LesserEvil, it's clear that larger legacy companies have been caught off guard by breakout “insurgent brands” — products that consumers regard as premium, made with cleaner ingredients, or simply better for them.

In 2024, global sales for premium F&B brands rose by 3% while mainstream brand volumes declined by 1%.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • IFF
  • Danone
  • Muller UK and Ireland
  • SuanNutra Inc
See more

You may also like

Finance

Danone acquires UK meal replacement brand Huel in €1bn functional nutrition deal

Read more
The French consumer goods giant is expanding its functional nutrition portfolio with the purchase of Huel, the plant-based complete food brand backed by actor Idris Elba, as demand driven by health-conscious consumers and GLP-1 drug users accelerates

Trending Articles

  1. Herbalife to acquire Bioniq to expand personalised nutrition capabilities Herbalife has agreed to acquire assets from UK-based Bioniq in a deal aimed at scaling data-driven personalised supplements globally, combining biomarker-based formulations with its distribution network
  2. European Patent Office invalidates key dsm-firmenich patent on high-potency microalgal DHA oils The EPO Appeal Board has ruled in favour of Mara Renewables, invalidating a dsm-firmenich patent relating to high-potency microalgal DHA oils following a two-day hearing, aligning with a recent UK Court of Appeal decision on the same patent
  3. The vitamin K2 supplement quality issue in the US: how to move forward Although a concerning number of K2 supplements on the market aren’t meeting label claims, there are ways that manufacturers can ensure they are selling high-quality and efficacious K2 products
  4. Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover Indian pharmaceutical giant Lupin Pharma is reportedly in early-stage negotiations to acquire UK supplement leader Vitabiotics for around £1 billion to capitalise on booming demand in India’s rapidly expanding nutraceutical market
  5. Affron granted first stress relief claim for a saffron ingredient in South Korea The ingredient is now the first and only saffron ingredient to be approved for a stress relief claim by the South Korean food regulation authority

Upcoming event

Making Nutraceuticals

21–22 April 2026 | Conference/Exhibition | Coventry, UK See all

You may also like

Finance

Danone acquires UK meal replacement brand Huel in €1bn functional nutrition deal

The French consumer goods giant is expanding its functional nutrition portfolio with the purchase of Huel, the plant-based complete food brand backed by actor Idris Elba, as demand driven by health-conscious consumers and GLP-1 drug users accelerates
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Regulatory roundup for nutraceuticals: news from the US and Europe

From fresh guidance on the FDA's Food Traceability Rule, to EFSA’s rapid outbreak assessment on cereulide in infant formula and rising antimicrobial resistance, regulators in the US and EU have issued key updates with implications for the nutraceutical supply chain
Finance

Metagenics acquires UK probiotic brand Symprove backed by Gryphon Investors

Metagenics has acquired UK-based probiotic brand Symprove and completed a strategic debt recapitalisation, strengthening its global practitioner-led supplements portfolio and positioning the business for further M&A and organic growth
Regulatory

Danone expands baby formula recall amid cereulide toxin concerns

Food safety alert deepens as additional Aptamil and Cow & Gate First Infant Milk and Follow-on Milk batches withdrawn from the market
Ingredients

Gonmisol and K. Patel join forces to bring Ayurvedic wellness to Europe

Exclusive partnership will introduce Ayurvedic wisdom for women’s wellness and metabolic health
Ingredients

Danone doubles down on gut health focus with The Akkermansia Company acquisition

This acquisition will gain Danone access to TAC's proprietary, research-backed Akkermansia muciniphila strain, MucT
Finance

Müller acquires Biotiful Gut Health in bid to increase functional beverage footprint

Through this acquisition, Müller will bolster its presence in the gut health beverage space, as consumers increasingly look for better-for-you drinks with added wellness benefits
Subscribe now